THE EFFICACY AND ADVERSE EFFECTS OF VASOCONSTRICTORS USED AS ADJUNCTS IN REGIONAL ANESTHESIA.
D000759:Adjuvants, Anesthesia; D000758:Anesthesia / Q000009:adverse effects*; D000765:Anesthesia, Conduction; D001127:Arginine Vasopressin; D004809:Ephedrine; D004837:Epinephrine; D006339:Heart Rate; D006801:Humans; D008616:Mephentermine; D008680:Metaraminol; D008729:Methoxamine; D009638:Norepinephrine; D010600:Pharmacology; D010656:Phenylephrine; D013566:Sympathomimetics; D013748:Tetracaine; D014116:Toxicology; D014662:Vasoconstrictor Agents; D014667:Vasopressins
D000759:Adjuvants, Anesthesia; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D013748:Tetracaine; D014667:Vasopressins; D001127:Arginine Vasopressin; D010656:Phenylephrine; D008680:Metaraminol; D004809:Ephedrine; D008729:Methoxamine; D008616:Mephentermine; D009638:Norepinephrine; D004837:Epinephrine
ANESTHESIA ADJUVANTS; ANESTHESIA COMPLICATIONS; ANESTHESIA, CONDUCTION; EPHEDRINE; EPINEPHRINE; MEPHENTERMINE; METARAMINOL; METHOXAMINE; NOREPINEPHRINE; PHARMACOLOGY; PHENYLEPHRINE; SYMPATHOMIMETICS; TETRACAINE; TOXICOLOGIC REPORT; VASOPRESSIN